LINC01365

Across TCGA pan-cancer cohorts, LINC01365 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC01365 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher LINC01365 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01365 expression acts as an unfavorable survival marker.

DLBC, BLCA, and PAAD are the cancer types where LINC01365 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	All	0.625	0.945	<.001	96	view →
BLCA	DFS	Tertile	All	0.240	0.630	.001	81	view →
PAAD	DFS	Tertile	All	0.006	0.505	<.001	45	view →
UCS	OS	Tertile	IV	0.269	0.624	.042	18	view →
LIHC	DFS	Tertile	All	0.232	0.547	.033	18	view →
CESC	OS	Tertile	All	0.611	0.877	.025	12	view →
KIRC	DFS	Tertile	All	0.470	0.645	.037	12	view →
BRCA	OS	Tertile	All	0.466	0.582	.045	6	view →
UCEC	OS	Tertile	All	0.887	0.928	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC01365–DLBC (OS)

Open the DLBC breakdown →